- Screening to assure eligibility and to determine level of risk and need
- Assessments to determine treatment and social needs
- Referral to licensed mental health/substance use treatment provider/agency at the appropriate level of care (outpatient, intensive outpatient, inpatient, and medication evaluation/follow up, medical needs) and other resources (job training, education, employment, housing etc.) as needed.
- Referral to recovery support self-help programs (Alcoholics Anonymous, Narcotics Anonymous, Recovery Coaches etc.) as appropriate.
- Weekly monitoring sessions
- Drug/alcohol testing
The potential client will be referred to CCBHCP through one of the above entities and a screening date will be scheduled. If the person qualifies, legal parties will be notified and an intake appointment will be schedule for the assessment process. Based on the results of the assessments, the clients are referred to community-based providers for appropriate treatment. Referrals may consist of regular counseling sessions with treatment providers, psychiatric medication evaluation with follow-ups, medical/dentist referrals and/or recovery support meetings and services. Referrals may also include GED tutoring, employment services/vocational training, parenting classes, affordable housing agencies as appropriate.
The client will meet at least weekly with CCBHCP Staff to monitor their progress and discuss additional needs of the client. Staff will as conduct regular clinical reviews with treatment providers for verification of progress and continual improvements or adjustments to the service plan as needed.
Random drug screenings are mandatory requirement for all clients who are diagnosed or indicate a substance use disorder.
Clients must appear for review hearings, which are scheduled regularly before the Court. During the review CCBHCP staff will provide the Court a clinical summary, level of participation in treatment and the program, results of drug screenings and any additional recommendations.
Program participation lasts for 90 days to 18 months based on compliance and clinical improvement.